C. Fung

发表

Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity

R. Frisina, N. Cox, E. Gamazon, 2016, Clinical Cancer Research.

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial

S. Kesler, C. Heckler, I. Kleckner, 2018, Supportive Care in Cancer.

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

S. Fosså, H. Sesso, D. Feldman, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma.

K. Loh, C. Fung, E. Guancial, 2016, Clinical genitourinary cancer.

Effects of Exercise on Inflammation in Patients Receiving Chemotherapy: A Nationwide NCORP Randomized Clinical Trial

C. Heckler, A. Onitilo, S. Mohile, 2019, Supportive Care in Cancer.

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

R. Frisina, S. Fosså, M. Dolan, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis.

C. Fung, S. Messing, W. Vitek, 2014, Fertility and sterility.

Testicular Cancer Survivorship: Looking Back to Move Forward.

C. Fung, L. Travis, 2021, Journal of Clinical Oncology.

Yoga for the Management of Cancer Treatment-Related Toxicities

S. Mohile, I. Kleckner, C. Kamen, 2018, Current Oncology Reports.

Postoperative radiation therapy for high-risk colon carcinoma.

C. Willett, C. Fung, C. Fung, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms

R. Frisina, E. Gamazon, S. Fosså, 2019, Clinical Cancer Research.

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.

E. Plimack, T. Guzzo, A. Balar, 2019, The oncologist.

Late adverse outcomes after treatment of testicular cancer

S. Fosså, C. Fung, A. Dahl, 2018, Der Onkologe.

Second primary head and neck cancer after Hodgkin lymphoma: A population‐based study of 44,879 survivors of Hodgkin lymphoma

L. Constine, C. Fung, M. Milano, 2015, Cancer.

Medicare accountable care organizations: post-acute care use and post-surgical outcomes in urologic cancer surgery.

R. Yousefi-Nooraie, J. Joseph, C. Fung, 2022, Urology.

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

R. Frisina, R. Huddart, D. Feldman, 2021, Cancer medicine.

Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor

K. Loh, C. Fung, 2017, Rare tumors.

Feasibility of utilizing a novel mhealth platform to deliver an evidence-based exercise intervention among testicular cancer survivors (TCS).

C. Heckler, S. Mohile, B. Ky, 2017 .

Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer

R. Frisina, M. Dolan, D. Feldman, 2022, Cancer medicine.

Increased risk of high-grade prostate cancer among testicular cancer survivors

E. Messing, Yuhchyau Chen, C. Fung, 2022, PloS one.

AGS and NIA bench‐to bedside conference summary: Cancer and cardiovascular disease

M. Rich, D. Forman, S. Mohile, 2022, Journal of the American Geriatrics Society.

Treatment of Metastatic Prostate Cancer in Older Adults

S. Mohile, K. Loh, C. Fung, 2016, Current Oncology Reports.

The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women’s Health Initiative

G. Anderson, R. Chlebowski, J. Roth, 2020, Breast Cancer Research and Treatment.

A Case Series of Transformation of Teratoma to Primitive Neuroectodermal Tumor: Evolving Management of a Rare Malignancy

E. Messing, C. Fung, R. Dunne, 2014, Rare tumors.

Testicular Cancer Survivorship.

S. Fosså, C. Fung, L. Travis, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer

E. Gamazon, S. Fosså, M. Dolan, 2017, Clinical Cancer Research.

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors

S. Fosså, C. Fung, Shirin Ardeshir-Rouhani-Fard, 2018, Advances in urology.

Complications associated with chemotherapy in testicular cancer management

D. Vaughn, C. Fung, 2011, Nature Reviews Urology.

677P A phase II study of enzalutamide (Enz) with dutasteride (Dut) or finasteride (Fin) in men ≥ 65 years with hormone-naive systemic prostate cancer (HNSPCa): Final analysis

E. Messing, S. Mohile, C. Fung, 2020 .

Biotoxicity of Chemotherapy

C. Fung, K. Pandya, 2014 .

A Festschrift in Honor of Edward M. Messing, MD, FACS

P. Okunieff, D. Rubens, R. Brasacchio, 2018, Bladder cancer.

Bladder cancer in the elderly patient: challenges and solutions

E. Messing, S. Mohile, C. Fung, 2015, Clinical interventions in aging.

Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study

P. Tamboli, E. Jonasch, C. Wood, 2017, BJU international.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

S. Fosså, C. Fung, L. Travis, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.

R. Uzzo, C. Fung, N. Haas, 2011, Hematology/oncology clinics of North America.

Prostate cancer in the elderly patient.

S. Mohile, W. Dale, C. Fung, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy

R. Frisina, H. Sesso, L. Einhorn, 2023, Journal of Cancer Survivorship.

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors

M. Dolan, D. Feldman, L. Einhorn, 2020, Clinical Cancer Research.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

S. Fosså, H. Sesso, S. Lipshultz, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy

Frederick G. Strathmann, S. Fosså, M. Dolan, 2019, Clinical Cancer Research.

Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study

S. Fosså, R. Huddart, K. Kroenke, 2021, Cancer Epidemiology, Biomarkers & Prevention.

Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

Derick R. Peterson, S. Fosså, C. Fung, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors

R. Frisina, S. Fosså, R. Huddart, 2020, JNCI cancer spectrum.

Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.

S. Fosså, M. Dolan, R. Huddart, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

S. Fosså, R. Huddart, H. Sesso, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

C. Kamen, C. Fung, M. Asare, 2016, Seminars in oncology nursing.

Exercise for Toxicity Management in Cancer-A Narrative Review.

I. Kleckner, F. Fleming, C. Fung, 2018, Oncology & hematology review.

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

C. Heckler, S. Mohile, I. Kleckner, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment

H. Sesso, C. Fung, L. Travis, 2023, Current Oncology Reports.

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy

S. Kesler, C. Heckler, I. Kleckner, 2018, Supportive Care in Cancer.

Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors

S. Fosså, D. Feldman, P. Monahan, 2020, JNCI cancer spectrum.

How to Manage Cisplatin-Based Chemotherapy–Related Cardiovascular Disease in Patients With Testicular Cancer

C. Fung, S. Kadambi, Suparna C Clasen, 2022, JACC. CardioOncology.

Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms

L. Hou, H. Sesso, C. Fung, 2021, Cardio-Oncology.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin‐based Chemotherapy: Application of the Framingham Risk Score

R. Frisina, S. Fosså, M. Dolan, 2018, Clinical genitourinary cancer.

Long-term Morbidity of Testicular Cancer Treatment.

S. Fosså, C. Fung, L. Travis, 2015, The Urologic clinics of North America.

Reply to G. Gandaglia et al.

S. Fosså, C. Fung, L. Travis, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second malignant neoplasms in testicular cancer survivors.

S. Fosså, C. Beard, C. Fung, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Effects of a Home‐based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy

S. Mohile, I. Kleckner, K. Loh, 2019, Journal of the American Geriatrics Society.

Association of falls with health-related quality of life (HRQOL) in older cancer survivors: A population based study.

S. Mohile, L. Lowenstein, W. Dale, 2016, Journal of geriatric oncology.

Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study.

E. Messing, S. Mohile, K. Noyes, 2014, The Journal of urology.

Assessment of coronary heart disease risk in testicular cancer survivors.

E. Mohler, D. Vaughn, C. Fung, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.

K. Loh, C. Fung, K. Mustian, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments

R. Frisina, S. Fosså, R. Huddart, 2022, Ear and hearing.

Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF)

K. Nathanson, N. Mitra, D. Vaughn, 2012, Front. Endocrin..

Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy

R. Frisina, S. Fosså, H. Sesso, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management

S. Fosså, L. Einhorn, P. Monahan, 2019, JNCI cancer spectrum.

Secondary malignant neoplasms in testicular cancer survivors.

C. Beard, C. Fung, S. Curreri, 2015, Urologic oncology.

Risk of solid cancer after chemotherapy

C. Fung, L. Travis, 2018, Nature Reviews Urology.

Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study.

C. Heckler, Ashwin A. Kotwal, S. Mohile, 2016, Journal of geriatric oncology.

Reply to S. Alanee et al.

S. Fosså, C. Fung, L. Travis, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

801TiP A phase II study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer (ABATE)

M. Milowsky, C. Fung, D. Kilari, 2020 .

A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma

L. Constine, C. Fung, M. Milano, 2018, Leukemia & lymphoma.

Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer?

C. Willett, C. Fung, C. Fung, 1999, The cancer journal from Scientific American.

Evaluating the effects of a structured exercise intervention on physical self-worth in men with prostate cancer: Addressing an unmet need.

C. Heckler, S. Mohile, I. Kleckner, 2019, Journal of Clinical Oncology.

Effect of exercise on quality of life (QoL) in 198 older patients with cancer: A URCC NCORP nationwide RCT.

S. Mohile, K. Loh, C. Fung, 2017 .

Re: Thyroid hypofunction in aging testicular cancer survivors

C. Fung, L. Travis, Paul C. Dinh, 2022, Acta oncologica.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

S. Fosså, R. Huddart, H. Sesso, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.

A. L. Frazier, C. Fung, J. Poynter, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adverse health outcomes in relationship to hypogonadism (HG) after platinum-based chemotherapy: A multicenter study of North American testicular cancer survivors (TCS).

S. Fosså, H. Sesso, D. Feldman, 2017 .

Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study.

S. Fosså, R. Huddart, H. Sesso, 2017 .

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

C. Heckler, S. Mohile, I. Kleckner, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Genome-wide association study (GWAS) of cisplatin-related hearing loss in testicular cancer survivors (TCS) to reveal associated variant in Wolfram syndrome 1 (WFS1) gene.

R. Frisina, E. Gamazon, M. Dolan, 2016 .

Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.

H. Sesso, C. Fung, S. Althouse, 2024, JAMA oncology.